Min Zhang, Fei Chen
Erythrocyte-based therapeutic delivery is valued for cargo protection and prolonged circulation, but this passive-carrier focus ignores the programmable intravascular interfaces now possible with erythrocytes. We propose a function-guided framework that matches designs to desired outcomes, serving as a guide to when erythrocytes could be the best choice for use as delivery vehicles.